Alliance Global Partners analyst Gaurav Mehta lowered the firm’s price target on Global Medical REIT (GMRE) to $11 from $12 and keeps a Buy rating on the shares following the Q4 report. The company is growing through acquisitions and formed a new joint venture, the analyst tells investors in a research note. The firm reduced 2025 funds from operations estimates to reflect Global Medical’s outlook.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMRE:
- Hold Rating on Global Medical REIT Amid Strategic Moves and Uncertainties
- Positive Outlook for Global Medical REIT: Strategic Investments and Strong Financial Performance
- Global Medical REIT reports Q4 adjusted FFO 22c, consensus 22c
- Global Medical REIT sees 2025 adjusted FFO 89c-93c, consensus 89c
- Global Medical REIT announces joint venture with Heitman